![](https://westcancercenter.org/wp-content/uploads/2022/04/West-Cancer-Center.jpg)
West Cancer Center & Research Institute, a pioneer in radiology technology, now has a recently FDA-approved radiopharmaceutical agent: prostate-specific membrane antigen (PSMA). This agent will be imaged with our state-of-art PET/CT imaging for men diagnosed with prostate cancer. According to the American Cancer Society, 1 in 8 men will be diagnosed with prostate cancer… Read more »